Amlodipine/chlortalidone/losartan - Hanmi Pharmaceutical
Alternative Names: Amlodipine/losartan/chlortalidone; Amosartan Plus; Chlortalidone/amlodipine/losartan; Chlortalidone/losartan/amlodipine; HCP 1401; Losartan/amlodipine/chlortalidone; Losartan/Chlortalidone/amlodipineLatest Information Update: 23 Nov 2017
At a glance
- Originator Hanmi Pharmaceutical
- Class Antihypertensives; Biphenyl compounds; Dihydropyridines; Heart failure therapies; Imidazoles; Ischaemic heart disorder therapies; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; Sodium chloride symporter Inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension